Physician profile
Chitra Tiruveedula
NPI 1043485287
$3,285.09
in general payments reported to CMS, 2019-2025
13 companies · $677 in 2025
The $677 reported for 2025 was more than what 93% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,554 · 2020: $120 · 2021: $151 · 2022: $211 · 2023: $306 · 2024: $265 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.78 |
| Education | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,010.03 | 2020-2025 | Invisalign |
| Patterson Companies, INC. | $767.59 | 2019-2022 | |
| Sirona Dental, INC. | $750.00 | 2019 | |
| Nobel Biocare USA | $219.33 | 2021-2023 | Nobelactive |
| 3m Company | $111.67 | 2020-2023 | Scotchbond Universal Plus, Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Biolase, INC. | $90.90 | 2023 | Waterlase Iplus |
| Dentsply Sirona INC | $80.11 | 2021-2024 | Waveone Gold Conform Fit, Orthophos E |
| Solventum Corporation | $72.43 | 2024 | 3m Filtek |
| Voco America INC. | $70.93 | 2019-2025 | Futurabond U, Rebilda Dc, Admira Fusion X-Tra |
| Straumann USA LLC | $42.24 | 2025 | |
| Premier Dental Products Company | $25.85 | 2019 | |
| Elevate Oral Care | $24.56 | 2024 | Fluorimax Mint, Just Right 5000, Advantage Arrest |
| Kulzer, LLC | $19.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitra Tiruveedula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.